首页> 外文OA文献 >Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

【2h】

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

机译：Bortezomib对多发性骨髓瘤的成本效益：系统审查

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wendong Chen; Yicheng Yang; Yi Chen; Fen Du; Huan Zhan;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of bortezomib for multiple myeloma: a systematic review [J] . Wendong Chen, Yicheng Yang, Yi Chen, ClinicoEconomics and Outcomes Research . 2016,第67期

机译：硼替佐米治疗多发性骨髓瘤的成本效益：系统评价
2. The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation [J] . Health technology assessment: HTA . 2011,第41期

机译：硼替佐米和沙利度胺联合烷基化剂和皮质类固醇激素联合治疗多发性骨髓瘤的一线治疗的临床疗效和成本效益：系统评价和经济评价
3. Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of?Phase III randomized controlled trials [J] . Xiaoping Liu, Colin K He, Xiangyu Meng, OncoTargets and therapy . 2015,第4期

机译：多发性骨髓瘤患者基于硼替佐米和非硼替佐米的移植后治疗：III期随机对照试验的系统评价和荟萃分析
4. Preliminary Large Scale Quantitative Proteomic Analysis of Bortezomib Resistant Multiple Myeloma [C] . Zhiping Wu, Xusheng Wang, Haiyan Tan, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：Bortezomib抗性多发性骨髓瘤的初步大规模定量蛋白质组学分析
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Cost-effectiveness of bortezomib for multiple myeloma: a systematic review [O] . Wendong Chen, Yicheng Yang, Yi Chen, 2016

机译：硼替佐米治疗多发性骨髓瘤的成本效益：系统评价
7. The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation [O] . Picot, J., Cooper, K., Bryant, J., 2011

机译：硼替佐米和沙利度胺联合使用烷化剂和皮质类固醇治疗多发性骨髓瘤一线治疗的临床疗效和成本效益：系统评价和经济评价

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

著录项

引文网络

相似文献

相关主题

期刊订阅